Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001835268-25-000014
Filing Date
2025-03-31
Accepted
2025-03-31 09:04:23
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cntb-20241231.htm   iXBRL 10-K 2237380
2 EX-10.15 cntb-20241231xexx1015.htm EX-10.15 27100
3 EX-10.16 cntb-20241231xexx1016.htm EX-10.16 49075
4 EX-10.17 cntb-20241231xexx1017.htm EX-10.17 34811
5 EX-10.18 cntb-20241231xexx1018.htm EX-10.18 258826
6 EX-19.1 cntb-20241231xexx191.htm EX-19.1 115183
7 EX-21.1 cntb-20241231xexx211.htm EX-21.1 6305
8 EX-23.1 cntb-20241231xexx231.htm EX-23.1 3980
9 EX-31.1 cntb-20241231xexx311.htm EX-31.1 10545
10 EX-31.2 cntb-20241231xexx312.htm EX-31.2 10533
11 EX-32.1 cntb-20241231xexx321.htm EX-32.1 6055
17 cntb-20241231_g1.jpg GRAPHIC 198123
18 cntb-20241231_g2.jpg GRAPHIC 53245
19 image_0.jpg GRAPHIC 246110
20 image_01.jpg GRAPHIC 8606
21 image_1.jpg GRAPHIC 102767
22 image_2a.jpg GRAPHIC 3199730
  Complete submission text file 0001835268-25-000014.txt   14929681

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntb-20241231.xsd EX-101.SCH 44747
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntb-20241231_cal.xml EX-101.CAL 83169
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntb-20241231_def.xml EX-101.DEF 250650
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntb-20241231_lab.xml EX-101.LAB 689644
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntb-20241231_pre.xml EX-101.PRE 483075
103 EXTRACTED XBRL INSTANCE DOCUMENT cntb-20241231_htm.xml XML 986966
Mailing Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130
Business Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40212 | Film No.: 25789177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)